Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

AZTA

Azenta (AZTA)

Azenta Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:AZTA
FechaHoraFuenteTítuloSímboloCompañía
21/11/202415:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AZTAAzenta Inc
19/11/202416:56PR Newswire (US)Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600NASDAQ:AZTAAzenta Inc
14/11/202415:24Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AZTAAzenta Inc
14/11/202407:00PR Newswire (US)Azenta to Participate in Stephens Annual Investment ConferenceNASDAQ:AZTAAzenta Inc
12/11/202415:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AZTAAzenta Inc
12/11/202415:05PR Newswire (US)Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFONASDAQ:AZTAAzenta Inc
04/11/202415:05PR Newswire (US)Azenta Announces Fiscal 2024 Fourth Quarter and Full Year Earnings Conference Call and WebcastNASDAQ:AZTAAzenta Inc
04/11/202407:41Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:AZTAAzenta Inc
04/11/202407:00PR Newswire (US)Azenta Announces the Addition of Three New Independent Directors Effective Immediately and New Initiative to Drive ValueNASDAQ:AZTAAzenta Inc
30/10/202415:05PR Newswire (US)Azenta Obtains Regulatory Approval for Clinical Long-Read Whole Genome Sequencing TestNASDAQ:AZTAAzenta Inc
04/09/202407:00PR Newswire (US)AZENTA ANNOUNCES APPOINTMENT OF JOHN P. MAROTTA AS CEONASDAQ:AZTAAzenta Inc
12/08/202415:05PR Newswire (US)GENEWIZ from Azenta Life Sciences Celebrates 25 Years of Advancing Scientific Discoveries at GENEWIZ Week EventNASDAQ:AZTAAzenta Inc
06/08/202415:50Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AZTAAzenta Inc
06/08/202415:05PR Newswire (US)Azenta Reports Third Quarter Results for Fiscal 2024, Ended June 30, 2024NASDAQ:AZTAAzenta Inc
05/08/202415:05PR Newswire (US)Azenta to Participate in 9th Annual Needham Virtual MedTech & Diagnostics 1x1 ConferenceNASDAQ:AZTAAzenta Inc
01/08/202415:26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AZTAAzenta Inc
24/07/202415:05PR Newswire (US)Azenta Announces Fiscal 2024 Third Quarter Earnings Conference Call and WebcastNASDAQ:AZTAAzenta Inc
22/07/202415:05PR Newswire (US)FinnGen Selects Azenta to Propel Personalized Medicine for Population Health StudyNASDAQ:AZTAAzenta Inc
04/06/202415:05PR Newswire (US)Azenta Announces Collaboration with the Crohn's & Colitis Foundation to Support its Crohn's Disease and Ulcerative Colitis Clinical ResearchNASDAQ:AZTAAzenta Inc
30/05/202407:01Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:AZTAAzenta Inc
23/05/202415:05PR Newswire (US)Azenta to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:AZTAAzenta Inc
13/05/202415:46PR Newswire (US)Azenta Opens the Doors to Its New Genomics Laboratory in Oxford, UKNASDAQ:AZTAAzenta Inc
08/05/202415:06PR Newswire (US)Azenta Announces CEO Succession PlanNASDAQ:AZTAAzenta Inc
08/05/202415:05PR Newswire (US)Azenta Reports Second Quarter Results for Fiscal 2024, Ended March 31, 2024NASDAQ:AZTAAzenta Inc
01/05/202415:05PR Newswire (US)Azenta Announces Fiscal 2024 Second Quarter Earnings Conference Call and WebcastNASDAQ:AZTAAzenta Inc
01/04/202415:15PR Newswire (US)Azenta Publishes its 2023 Environmental, Social, & Governance (ESG) ReportNASDAQ:AZTAAzenta Inc
01/04/202415:05PR Newswire (US)Azenta to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:AZTAAzenta Inc
12/03/202407:00PR Newswire (US)Azenta to Participate in the Virtual KeyBanc Life Sciences & MedTech Investor ForumNASDAQ:AZTAAzenta Inc
07/02/202415:05PR Newswire (US)Azenta Reports First Quarter Results for Fiscal 2024, Ended December 31, 2023NASDAQ:AZTAAzenta Inc
02/02/202407:00PR Newswire (US)Azenta Launches the BioArc™ Ultra, a Breakthrough, Automated Solution for Efficient, Eco-Friendly Ultracold Sample ManagementNASDAQ:AZTAAzenta Inc
 Showing the most relevant articles for your search:NASDAQ:AZTA